• Je něco špatně v tomto záznamu ?

Mortality of registered drug users in Central Asia

V. Mravcik, T. Zabransky, A. Talu, E. Jasaitis, N. Gafarova, Z. Musabekova, L. Baymirova, M. Makhsutov, F. Ganiev,

. 2014 ; 25 (6) : 1215-20. [pub] 20140406

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15031997

BACKGROUND: Within the fifth phase of the Central Asia Drug Action Programme (CADAP) covering five post-Soviet Central Asian countries, an analysis of the mortality of drug users was performed. The results for Kazakhstan and Uzbekistan are presented in detail in this paper since results from Kyrgyzstan and Tajikistan are not considered valid and Turkmenistan did not provide data at all. METHODS: A system of registration of all users of illegal drugs known to the health and/or law enforcement authorities ("narcological registers") exists in Central Asian countries inherited from the system of Soviet "narcology". According to the legal norms, the death of a registered person should be recorded. We conducted indirect standardisation of crude mortality rates and computed the standardised mortality ratio (SMR) comparing observed number of deaths with expected number of deaths according to age and gender specific mortality rates in the general population of the same country. RESULTS: The results show excess mortality in registered drug users, particularly in registered females, in Uzbekistan (the latest available SMR for all those registered is 7.4; the SMR in females is 16.3) and Kazakhstan (4.0 and 12.9). The excess mortality is highest among young adults (18-34) in all the studies. CONCLUSION: Taking into account the limited quality and reliability of the data - first of all, the likely under-reporting of deaths in the narcological registers - the crude mortality rate among registered drug users is quite high when compared to EU countries. The SMR in total is comparably lower as a result of the high background mortality in the general population. This excess mortality is preventable and should be targeted by the national drug policies. Specifically, the programmes should target registered and unregistered female drug users.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15031997
003      
CZ-PrNML
005      
20230718144229.0
007      
ta
008      
151005s2014 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.drugpo.2014.03.007 $2 doi
035    __
$a (PubMed)24935888
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Mravcik, Viktor $u ResAd, Prague - Research and Development in Drug Epidemiology and Policy, Prague, Czech Republic; Department of Addictology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic; National Monitoring Centre for Drugs and Drug Addiction, Czech Republic.
245    10
$a Mortality of registered drug users in Central Asia / $c V. Mravcik, T. Zabransky, A. Talu, E. Jasaitis, N. Gafarova, Z. Musabekova, L. Baymirova, M. Makhsutov, F. Ganiev,
520    9_
$a BACKGROUND: Within the fifth phase of the Central Asia Drug Action Programme (CADAP) covering five post-Soviet Central Asian countries, an analysis of the mortality of drug users was performed. The results for Kazakhstan and Uzbekistan are presented in detail in this paper since results from Kyrgyzstan and Tajikistan are not considered valid and Turkmenistan did not provide data at all. METHODS: A system of registration of all users of illegal drugs known to the health and/or law enforcement authorities ("narcological registers") exists in Central Asian countries inherited from the system of Soviet "narcology". According to the legal norms, the death of a registered person should be recorded. We conducted indirect standardisation of crude mortality rates and computed the standardised mortality ratio (SMR) comparing observed number of deaths with expected number of deaths according to age and gender specific mortality rates in the general population of the same country. RESULTS: The results show excess mortality in registered drug users, particularly in registered females, in Uzbekistan (the latest available SMR for all those registered is 7.4; the SMR in females is 16.3) and Kazakhstan (4.0 and 12.9). The excess mortality is highest among young adults (18-34) in all the studies. CONCLUSION: Taking into account the limited quality and reliability of the data - first of all, the likely under-reporting of deaths in the narcological registers - the crude mortality rate among registered drug users is quite high when compared to EU countries. The SMR in total is comparably lower as a result of the high background mortality in the general population. This excess mortality is preventable and should be targeted by the national drug policies. Specifically, the programmes should target registered and unregistered female drug users.
650    _2
$a věkové rozložení $7 D017677
650    _2
$a uživatelé drog $x statistika a číselné údaje $7 D055030
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a registrace $x statistika a číselné údaje $7 D012042
650    _2
$a sexuální faktory $7 D012737
650    _2
$a poruchy spojené s užíváním psychoaktivních látek $x mortalita $7 D019966
651    _2
$a Kazachstán $x epidemiologie $7 D007623
651    _2
$a Uzbekistán $x epidemiologie $7 D014610
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Zábranský, Tomáš, $d 1969-2021 $u ResAd, Prague - Research and Development in Drug Epidemiology and Policy, Prague, Czech Republic; Department of Addictology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic. Electronic address: twz@resad.cz. $7 ola2003201138
700    1_
$a Talu, Ave $u ResAd, Prague - Research and Development in Drug Epidemiology and Policy, Prague, Czech Republic; Department of Public Health, University of Tartu, Estonia.
700    1_
$a Jasaitis, Ernestas $u ResAd, Prague - Research and Development in Drug Epidemiology and Policy, Prague, Czech Republic; Drug Control Department under the Government of the Republic of Lithuania, Lithuanian REITOX National Focal Point, Lithuania.
700    1_
$a Gafarova, Nuriya $u National Research Center on Medical and Social Problems of Drug Addiction, Kazakhstan.
700    1_
$a Musabekova, Zhannat $u National Research Center on Medical and Social Problems of Drug Addiction, Kazakhstan.
700    1_
$a Baymirova, Luiza $u Ministry of Health of the Republic of Uzbekistan, Uzbekistan.
700    1_
$a Makhsutov, Makhsut $u National Center for Monitoring and Prevention of Drug Addiction, Tajikistan.
700    1_
$a Ganiev, Furkat $u National Center for Forensic Medicine and Toxicology, Tajikistan.
773    0_
$w MED00008614 $t The International journal on drug policy $x 1873-4758 $g Roč. 25, č. 6 (2014), s. 1215-20
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24935888 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20151005 $b ABA008
991    __
$a 20230718144225 $b ABA008
999    __
$a ok $b bmc $g 1092873 $s 915123
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 25 $c 6 $d 1215-20 $e 20140406 $i 1873-4758 $m The International journal on drug policy $n Int J Drug Policy $x MED00008614
LZP    __
$a Pubmed-20151005
Zpět

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace